Price $97.94 |
Market Cap
174.72B
|
Sector Health Care |
Div. Growth
11.10%
|
|
P/E
17.5
|
P/B
-
|
P/S
4.3
|
Dividend %
4.80%
|
|
P/CF
4.1
|
P/FCF
20.9
|
Op. Cash Flow
14.12M
|
FCF
4.7
|
|
Op. Margin
39.90%
|
Net Margin
24.60%
|
ROE
-103.70%
|
ROI
21.20%
|
|
ROA
11.30%
|
EPS Growth
62.30%
|
Current Ratio
3.2
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Champions Oncology Inc (CSBR) | $9.37 | - | - | 114.4M | Strong Buy |
| Diversicare Healthcare Service (DVCR) | $1.67 | - | - | 11.3M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $11.61 | - | - | 13.29B | Strong Buy |
| Endo International PLC (ENDP) | $3.36 | - | - | 806.3M | Strong Buy |
| Elite Pharmaceuticals Inc (ELTP) | $0.08 | - | - | 65.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
